A groundbreaking sensor technology known as the “Canary on a Chip” has been developed by researchers at the University at Buffalo, enabling rapid testing of cells for various stimuli like antibiotics, pathogens, toxins, and more within minutes. The sensor, detailed in an article in Analytical Chemistry, leverages the relationship between cell volume and the cell environment, termed cell volume cytometry, to provide quick and accurate results without the need for bacterial culture for antibiotic sensitivity assessment.
The core of this technology is a tiny silicon chip designed by Susan Z. Hua, Ph.D., and her team, which houses the cells for testing within a sensor chamber. The sensor’s high sensitivity allows for detecting minute changes in cell dimensions never observed before in living cells, making it a powerful tool for assessing cellular responses in real-time. The simplicity of the sensor lies in its use of electrical impedance, where changes in cell volume affect the resistance to electric current flow, indicating cellular reactions such as swelling in response to toxins.
The versatility of the “Canary on a Chip” sensor extends beyond bacteria to encompass a wide range of biological components enclosed by a membrane, including single proteins, mitochondria, chloroplasts, cell nuclei, and whole cells. This technology holds promise for applications such as rapid evaluation of cancer cells for chemotherapy effectiveness, screening toxins relevant to bioterrorism, and drug screening due to its portability, cost-effectiveness, and real-time capabilities. The authors highlight the sensor’s potential as a frontline indicator of cellular activity due to its ability to monitor both normal and abnormal biological processes that impact cell volume.
The sensor’s ability to swiftly assess the effectiveness of antibiotics against specific bacteria, like different strains of E. coli, in under 10 minutes at room temperature showcases its efficiency. According to Frederick Sachs, Ph.D., the sensor can deliver even faster results at higher temperatures, underscoring its utility in time-sensitive scenarios. The technology’s simplicity, low power requirements, and real-time capabilities make it a valuable tool for a wide array of applications, from assessing chemotherapy or radiation protocols to screening for toxins and drug compounds.
The research team, which includes Daniel A. Ateya, Philip A. Gottlieb, and Steve Besch, has filed a patent for this innovative technology. Supported by grants from the National Science Foundation and the National Institutes of Health, the development of this sensor highlights the potential for rapid, accurate, and cost-effective cellular assays with broad applications in biomedicine, biotechnology, and beyond.
Key Takeaways:
– The “Canary on a Chip” sensor technology developed by the University at Buffalo enables rapid assessment of cellular responses to various stimuli, providing results in minutes.
– Leveraging the connection between cell volume and the cell environment, the sensor’s high sensitivity allows for detecting minute changes in cell dimensions, making it a versatile tool for a range of biological components.
– The sensor’s simplicity, low power requirements, and real-time capabilities make it suitable for diverse applications, including drug screening, cancer cell evaluation, and toxin detection.
– Supported by grants from prestigious institutions, the researchers have patented this innovative technology, paving the way for enhanced cellular assays with broad implications for research and industry.
Read more on buffalo.edu